BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 14507864)

  • 1. Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages.
    Burton MJ; Holland MJ; Faal N; Aryee EA; Alexander ND; Bah M; Faal H; West SK; Foster A; Johnson GJ; Mabey DC; Bailey RL
    Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4215-22. PubMed ID: 14507864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community.
    West ES; Munoz B; Mkocha H; Holland MJ; Aguirre A; Solomon AW; Bailey R; Foster A; Mabey D; West SK
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):83-7. PubMed ID: 15623758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjunctival chlamydial 16S ribosomal RNA expression in trachoma: is chlamydial metabolic activity required for disease to develop?
    Burton MJ; Holland MJ; Jeffries D; Mabey DC; Bailey RL
    Clin Infect Dis; 2006 Feb; 42(4):463-70. PubMed ID: 16421789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for control of trachoma: observational study with quantitative PCR.
    Solomon AW; Holland MJ; Burton MJ; West SK; Alexander ND; Aguirre A; Massae PA; Mkocha H; Muñoz B; Johnson GJ; Peeling RW; Bailey RL; Foster A; Mabey DC
    Lancet; 2003 Jul; 362(9379):198-204. PubMed ID: 12885481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities.
    Burton MJ; Holland MJ; Makalo P; Aryee EA; Sillah A; Cohuet S; Natividad A; Alexander ND; Mabey DC; Bailey RL
    PLoS Negl Trop Dis; 2010 Oct; 4(10):. PubMed ID: 20957147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study.
    Burton MJ; Holland MJ; Makalo P; Aryee EA; Alexander ND; Sillah A; Faal H; West SK; Foster A; Johnson GJ; Mabey DC; Bailey RL
    Lancet; 2005 Apr 9-15; 365(9467):1321-8. PubMed ID: 15823382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality assessment of conjunctival specimens for detection of Chlamydia trachomatis by PCR in children with active trachoma.
    de Barbeyrac B; Goldschmidt P; Malembic S; Raherison S; Clerc M; Bodaghi B; Bébéar C; Chaumeil C
    Clin Microbiol Infect; 2007 Jul; 13(7):689-94. PubMed ID: 17441975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Chlamydia trachomatis ocular infection in trachoma-endemic communities by rRNA amplification.
    Yang JL; Hong KC; Schachter J; Moncada J; Lekew T; House JI; Zhou Z; Neuwelt MD; Rutar T; Halfpenny C; Shah N; Whitcher JP; Lietman TM
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):90-4. PubMed ID: 18689701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma.
    Yang JL; Schachter J; Moncada J; Habte D; Zerihun M; House JI; Zhou Z; Hong KC; Maxey K; Gaynor BD; Lietman TM
    Br J Ophthalmol; 2007 Mar; 91(3):293-5. PubMed ID: 17050583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal.
    Harding-Esch EM; Holland MJ; Schémann JF; Sillah A; Sarr B; Christerson L; Pickering H; Molina-Gonzalez S; Sarr I; Andreasen AA; Jeffries D; Grundy C; Mabey DCW; Herrmann B; Bailey RL
    Parasit Vectors; 2019 Oct; 12(1):497. PubMed ID: 31640755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
    Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
    Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community.
    Ramadhani AM; Derrick T; Macleod D; Massae P; Malisa A; Mbuya K; Mtuy T; Makupa W; Roberts CH; Bailey RL; Mabey DCW; Holland MJ; Burton MJ
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007559. PubMed ID: 31306419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydial positivity of nasal discharge at baseline is associated with ocular chlamydial positivity 2 months following azithromycin treatment.
    Gower EW; Solomon AW; Burton MJ; Aguirre A; Muñoz B; Bailey R; Holland M; Makalo P; Massae P; Mkocha H; Mabey DC; West SK
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4767-71. PubMed ID: 17065486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?
    Harding-Esch EM; Edwards T; Sillah A; Sarr I; Roberts CH; Snell P; Aryee E; Molina S; Holland MJ; Mabey DC; Bailey RL
    PLoS Negl Trop Dis; 2009 Dec; 3(12):e573. PubMed ID: 20027217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does clinical diagnosis indicate ocular chlamydial infection in areas with a low prevalence of trachoma?
    Thein J; Zhao P; Liu H; Xu J; Jha H; Miao Y; Pizzarello L; Tapert L; Schachter J; Mabon M; Osaki-Holm S; Lietman T; Paxton A
    Ophthalmic Epidemiol; 2002 Oct; 9(4):263-9. PubMed ID: 12187424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for active trachoma and ocular Chlamydia trachomatis infection in treatment-naïve trachoma-hyperendemic communities of the Bijagós Archipelago, Guinea Bissau.
    Last AR; Burr SE; Weiss HA; Harding-Esch EM; Cassama E; Nabicassa M; Mabey DC; Holland MJ; Bailey RL
    PLoS Negl Trop Dis; 2014 Jun; 8(6):e2900. PubMed ID: 24967629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of molecular tools in the control of blinding trachoma.
    Mabey D; Solomon AW
    Am J Trop Med Hyg; 2003 Nov; 69(5 Suppl):11-7. PubMed ID: 14692675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extent and kinetics of genetic change in the omp1 gene of Chlamydia trachomatis in two villages with endemic trachoma.
    Hayes LJ; Pecharatana S; Bailey RL; Hampton TJ; Pickett MA; Mabey DC; Watt PJ; Ward ME
    J Infect Dis; 1995 Jul; 172(1):268-72. PubMed ID: 7797929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persisting inapparent chlamydial infection in a trachoma endemic community in The Gambia.
    Ward M; Bailey R; Lesley A; Kajbaf M; Robertson J; Mabey D
    Scand J Infect Dis Suppl; 1990; 69():137-48. PubMed ID: 2263890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjunctival FOXP3 expression in trachoma: do regulatory T cells have a role in human ocular Chlamydia trachomatis infection?
    Faal N; Bailey RL; Jeffries D; Joof H; Sarr I; Laye M; Mabey DC; Holland MJ
    PLoS Med; 2006 Aug; 3(8):e266. PubMed ID: 16881731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.